STERIS (NYSE:STE – Get Free Report) issued an update on its FY 2027 earnings guidance on Wednesday morning. The company issued revenue guidance of $6.4 billion-$6.4 billion, compared to the consensus revenue estimate of $6.4 billion. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $277.25. Neutral Sentiment: Full-year outlook was maintained: Fiscal 2027 adjusted EPS guidance is $11.00–$11.30, near the $11.16 analyst consensus, while revenue guidance remains about $6.4 billion. Fiscal 2027 adjusted EPS guidance is $11.00–$11.30, near the $11.16 analyst consensus, while revenue guidance remains about $6.4 billion.